by admin | May 4, 2024 | Article
April 29, 2024 – Lupus Canada is pleased to share that Benlysta (indication Lupus Nephritis) is listed in Ontario effective April 17, 2024. SUMMARY OF PRODUCT CHANGES We are pleased to provide you with the Summary of Changes – April 2024 to Edition No. 43 of...
by admin | May 4, 2024 | Article
April 23, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in PEI effective April 23, 2024. For more information, please visit the PEI Pharmacare Program website.
by admin | May 4, 2024 | Article
April 22, 2024 – “Georgia Lefas had been feeling exhausted for more than year. The mornings were especially hard. It was taking Lefas, an obstetrician-gynecologist, longer to recover from her nighttime call-outs to deliver babies. The marathon runner found...
by admin | May 4, 2024 | Article
March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024. For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf
by admin | May 4, 2024 | Article
March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...
